Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GYRE | GYRE THERAPEUTICS INC | $7.80 | $4.35 | 79.25% | 130.00x | -23.90x | 5.98x | 7.13x | 0.67x | -$150.00k | -0.03% | $106.03M | 1.19 | $720.19M | 56.08 | ||
| SLNO | SOLENO THERAPEUTICS INC | $52.87 | $40.51 | 30.51% | 132.18x | 13.32x | 14.11x | 6.06x | 0.48x | $46.73M | 1.74% | $450.12M | 8.86 | $2.71B | 93.54 | ||
| ADMA | ADMA BIOLOGICS INC | $10.52 | $11.42 | -7.90% | 16.97x | 10.80x | 4.91x | 5.25x | 0.45x | $27.82M | 1.11% | $477.32M | 2.00 | $2.49B | 12.59 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $296.11 | $93.69 | 216.04% | 67.92x | 43.38x | 9.18x | 36.76x | 1.46x | $641.34M | 1.63% | $1.08B | 8.09 | $40.79B | 44.13 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $10.07 | $18.31 | -45.01% | 7.19x | 20.31x | 5.23x | 3.82x | 0.32x | -$1.99M | -0.36% | $154.66M | 2.80 | $592.03M | 5.96 | ||
| CORT | CORCEPT THERAPEUTICS INC | $51.42 | $16.17 | 218.06% | 111.78x | 94.77x | 6.98x | 8.65x | 1.30x | $119.79M | 2.23% | $637.99M | 6.11 | $5.42B | -789.53 | ||
| HALO | HALOZYME THERAPEUTICS INC | $63.96 | $68.95 | -7.23% | 24.23x | 7.82x | 5.49x | 154.64x | 0.40x | $644.59M | 8.41% | $48.81M | 0.41 | $9.55B | 16.67 | ||
| KRYS | KRYSTAL BIOTECH INC | $266.04 | $106.68 | 149.38% | 37.58x | 34.17x | 19.79x | 6.38x | 1.34x | $189.35M | 2.46% | $1.22B | 42.14 | $7.29B | 37.19 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $4.85 | $3.29 | 47.46% | 22.05x | 17.45x | 2.97x | 5.07x | 0.80x | $13.21M | 3.44% | $76.53M | 0.97 | $326.42M | 16.62 | ||
| VCEL | VERICEL CORP | $35.57 | $8.31 | 328.21% | 107.79x | 80.62x | 6.48x | 5.09x | 1.88x | $24.75M | 1.38% | $354.64M | 7.05 | $1.80B | 51.63 | ||
| RPRX | ROYALTY PHARMA PLC | $49.47 | $40.96 | 20.77% | 27.64x | 9.57x | 8.94x | 2.94x | 0.55x | $2.22B | 10.43% | $9.71B | 22.60 | $36.87B | 34.18 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $55.27 | $16.32 | 238.65% | 56.40x | 50.10x | 5.61x | 7.02x | 1.73x | $164.23M | 3.88% | $605.69M | 7.92 | $4.07B | 36.52 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $54.06 | $46.28 | 16.82% | 29.70x | 12.36x | 3.22x | 1.71x | 0.51x | $724.96M | 6.99% | $6.09B | 31.74 | $9.68B | 16.90 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $31.83 | $35.46 | -10.23% | 11.53x | 8.67x | 2.11x | 2.12x | 0.53x | $347.89M | 19.01% | $870.22M | 15.14 | $1.25B | 4.91 | ||
| MNKD | MANNKIND CORP | $2.84 | $1.05 | 169.79% | 142.00x | 326.44x | 2.49x | -17.15x | 1.04x | $13.69M | 1.58% | -$51.02M | -0.17 | $1.41B | 26.55 | ||
| APLS | APELLIS PHARMACEUTICALS INC | $40.96 | $4.97 | 723.82% | 227.56x | -34.72x | 5.15x | 14.15x | 3.53x | $45.01M | 0.87% | $370.15M | 2.93 | $5.24B | 74.90 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $227.44 | $107.61 | 111.35% | 35.32x | 23.73x | 16.41x | 4.46x | 1.08x | $48.09M | 1.09% | $1.02B | 52.60 | $4.81B | 24.13 | ||
| EXEL | EXELIXIS INC | $43.68 | $34.65 | 26.07% | 15.17x | 13.67x | 5.11x | 5.25x | 0.79x | $875.84M | 7.38% | $2.16B | 7.96 | $11.03B | 11.10 | ||
| TECH | BIO-TECHNE CORP | $55.02 | $15.28 | 260.12% | 105.81x | 27.20x | 7.05x | 4.28x | 1.52x | $223.02M | 2.60% | $2.01B | 12.90 | $8.79B | 38.80 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $28.74 | $14.62 | 96.57% | 16.42x | 14.99x | 5.97x | 3.68x | 1.92x | $208.61M | 5.94% | $954.27M | 7.80 | $2.80B | 8.71 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $423.92 | $183.41 | 131.13% | 27.42x | 21.77x | 9.03x | 5.77x | 1.47x | $3.19B | 2.95% | $18.67B | 73.00 | $104.45B | 21.46 | ||
| MDXG | MIMEDX GROUP INC | $3.68 | $2.36 | 56.09% | 17.52x | 32.80x | 1.40x | 2.26x | 1.04x | $69.36M | 12.69% | $242.94M | 1.64 | $405.94M | 7.45 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $701.42 | $434.16 | 61.56% | 16.48x | 14.96x | 4.89x | 2.34x | 1.19x | $4.11B | 5.64% | $31.42B | 302.15 | $73.28B | 12.76 | ||
| VCYT | VERACYTE INC | $33.09 | $10.08 | 228.12% | 39.39x | 31.22x | 5.03x | 2.01x | 2.06x | $126.63M | 4.87% | $1.31B | 16.67 | $2.30B | 24.89 | ||
| UTHR | UNITED THERAPEUTICS CORP | $570.40 | $263.00 | 116.88% | 18.93x | 19.52x | 7.94x | 3.52x | 1.97x | $1.04B | 4.12% | $7.10B | 160.19 | $23.44B | 12.89 | ||
| INCY | INCYTE CORP | $96.91 | $64.35 | 50.60% | 13.29x | 12.52x | 3.60x | 3.44x | 1.34x | $1.45B | 7.51% | $5.62B | 28.21 | $15.93B | 8.52 | ||
| XOMA | XOMA ROYALTY CORP | $41.38 | $9.83 | 321.01% | 27.05x | 84.52x | 9.59x | 5.87x | 9.20x | -$1.83M | -0.36% | $83.94M | 6.95 | $535.86M | 15.45 | ||
| PBYI | PUMA BIOTECHNOLOGY INC | $7.49 | $3.84 | 95.17% | 12.08x | 18.36x | 1.64x | 2.92x | 5.34x | $41.73M | 11.13% | $130.34M | 2.61 | $377.88M | 7.08 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.